Advertisement

Journal of General Internal Medicine

, Volume 24, Supplement 2, pp 412–416 | Cite as

Cancer-Related Fatigue: The Approach and Treatment

  • Carmen P. Escalante
  • Ellen F. ManzulloEmail author
Review

Abstract

As the volume of cancer survivors continues to increase, clinicians are being faced with a growing number of patients with cancer-related fatigue (CRF). Survivors with a variety of malignancies may experience fatigue. Many potential barriers to the identification of this symptom in a cancer survivor may exist, due in part to both the patient and the clinician. Assessment of patients for fatigue is important because it can profoundly effect their daily lives. Many factors contribute to CRF. Hence, the clinician may face a daunting challenge in attempting to alleviate CRF. Treatment modalities for CRF include nonpharmacologic interventions, such as psychosocial interventions, exercise, sleep therapy, and acupuncture. Pharmacologic interventions include stimulants, namely modafinil and methylphenidate. In some patients antidepressants may be beneficial. Clinicians should assess cancer survivors for the presence of fatigue and focus on its treatment in an attempt to ensure that these patients have the best possible symptom control.

KEY WORDS

cancer-related fatigue cancer survivors exercise stimulants 

Notes

Acknowledgments

No funding was received for the preparation of this manuscript.

Conflict of Interest

Dr. Manzullo has no potential conflict of interest. Dr. Escalante has a research grant agreement with Ortho-McNeil.

References

  1. 1.
    Cancer Survivorship - United States, 1971–2001. MMWR. Morb Mortal Wkly Rep. 2004; 53: 526–9.Google Scholar
  2. 2.
    Mock V, Atkinson A, Barsevick A, et al. NCCN. Practice guidelines for cancer related fatigue.Oncology (Huntington). 2000;14:151–61.Google Scholar
  3. 3.
    Smets EMA, Garssen B, Schuster-Uitterhoeve ALJ, et al. Fatigue in cancer patients. Br J Cancer. 1993;68(2):220–4.PubMedGoogle Scholar
  4. 4.
    Berglund G, Bolund C, Fornander T, et al. Late effects of adjuvant chemotherapy and postoperative radiotherapy on quality of life among breast cancer patients. Eur J Cancer Care. 1991;27(9):1075–81.Google Scholar
  5. 5.
    Devlen J, Maguire P, Phillips P, et al. Psychological problems associated with diagnosis and treatment of lymphoma. BMJ. 1987;295:955–7.CrossRefPubMedGoogle Scholar
  6. 6.
    Lutgendorf SK, Anderson B, Ullrich P, et al. Quality of life and mood in women gynecologic cancer: a one year prospective study. Cancer (Phil). 2002;94:131–40.CrossRefGoogle Scholar
  7. 7.
    Ersek M, Ferrell BR, Dow KH, Melancon CH. Quality of life in women with ovarian cancer. West J Nurs Res. 1997;19:334–50.CrossRefPubMedGoogle Scholar
  8. 8.
    Fossa SD, Dahl AA, Loge JH. Fatigue, anxiety, and depression in long-term survivors of testicular cancer. J Clin Oncol. 2003;21(7):1249–54.CrossRefPubMedGoogle Scholar
  9. 9.
    Hann DM, Jacobsen PB, Martin SC, et al. Fatigue in women treated with bone marrow transplantation for breast cancer: a comparison with women with no history of cancer. Support Care Cancer. 1997;5(1):44–52.CrossRefPubMedGoogle Scholar
  10. 10.
    Cella D, Davis K, Breitbart W, Curt G.Cancer-related fatigue: prevalence pf proposed diagnostic criteria in a United States sample of cancer survivors. J Clin Oncol. 2001;19:3385–91.PubMedGoogle Scholar
  11. 11.
    Knobel H, Havard Loge J, Brit Lund M, Forfang K, Nome O, Kaasa S. Late medical complications and fatigue in Hodgkins’Google Scholar
  12. 12.
    Bower JE, Ganz PA, Aziz N, et al. T-cell homeostasis in breast cancer survivors with persistent fatigue. J Natl Cancer Inst. 2003;95:1165–8.PubMedCrossRefGoogle Scholar
  13. 13.
    Bower JE, Ganz PA, Aziz N, et al. Fatigue and proinflammatory cytokine activity in breast cancer survivors. Psychosom Med. 2002;64:604–11.PubMedGoogle Scholar
  14. 14.
    Mock V, Atkinson A, Barsevick AM, et al. Cancer-related fatigue. Clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2007;5:1054–78.PubMedGoogle Scholar
  15. 15.
    Barsevick AM, Dudley W, Beck S, et al. A randomized clinical trial of energy conservation for patients with cancer-related fatigue. Cancer. 2004;100:1302–10.CrossRefPubMedGoogle Scholar
  16. 16.
    Richardson A, Ream EK. Self-care behaviours initiated by chemotherapy patients in response to fatigue. Int J Nurs Stud. 1997;34:35–43.CrossRefPubMedGoogle Scholar
  17. 17.
    Yates P, Aranda S, Hargraves M, et al. Randomized controlled trial of an educational intervention for managing fatigue in women receiving adjuvant chemotherapy for early-stage breast cancer. J Clin Oncol. 2—5;23:6027–36.Google Scholar
  18. 18.
    Fawzy FI, Cousins N, Fawzy NW, et al. A structured psychiatric intervention for cancer patients. I. Changes over time in methods of coping and affective disturbance. Arch Gen Psychiatry. 1990;47:720–5.PubMedGoogle Scholar
  19. 19.
    Fawzy NW. A psychoeducational nursing intervention to enhance coping and affective state in newly diagnosed malignant melanoma patients. Cancer Nurs. 1995;18:427–38.CrossRefPubMedGoogle Scholar
  20. 20.
    Gaston-Johansson F, Fall-Dickson JM, Nanda J, et al. The effectiveness of the comprehensive coping strategy program on clinical outcomes in breast cancer autologous bone marrow transplantation. Cancer Nurs. 2000;23:277–85.CrossRefPubMedGoogle Scholar
  21. 21.
    Jacobsen PB, Meade CD, Stein KD et al. Efficacy and costs of two forms of stress management training for cancer patients undergoing chemotherapy. J Clin Oncol. 2002;20:2851–62.CrossRefPubMedGoogle Scholar
  22. 22.
    Given B, Given CW, McCorkle R, et al. Pain and fatigue management: results of a nursing randomized clinical trial. Oncol Nurs Forum. 2002;29:949–56.CrossRefPubMedGoogle Scholar
  23. 23.
    Jacobsen PB, Donovan KA, Vadaparampil ST, et al. Systematic review and meta-analysis of psychological and activity-based interventions for cancer-related fatigue. Health Psychol. 2007;26:660–7.CrossRefPubMedGoogle Scholar
  24. 24.
    Segal R, Evans W, Johnson D, et al. Structured exercise improves physical functioning in women with stages I and II breast cancer: results of a randomized controlled trial. J Clin Oncol. 2001;19:657–65.PubMedGoogle Scholar
  25. 25.
    Windsor PM, Nicol KF, Potter J. A randomized, controlled trial of aerobic exercise for treatment-related fatigue in men receiving radical external beam radiotherapy for localized prostate carcinoma. Cancer. 2004;101:550–7.CrossRefPubMedGoogle Scholar
  26. 26.
    Galvao DA, Newton RU. Review of exercise intervention studies in cancer patients. J Clin Oncol. 2005;23:899–909.CrossRefPubMedGoogle Scholar
  27. 27.
    McNeely ML, Campbell KL, Rowe BH, et al. Effects of exercise on breast cancer patients and survivors: a systematic review and meta-analysis. CMAJ. 2006;175:34–41.PubMedGoogle Scholar
  28. 28.
    Kangas M, Bovbjerg DH, Montgomery GH. Cancer-related fatigue: a systematic and meta-analytic review of non-pharmacological therapies for cancer patients. Psychol Bull. 2008;134:700–41.CrossRefPubMedGoogle Scholar
  29. 29.
    Dimeo F, Schwartz S, Wesel N, et al. Effects of an endurance and resistance exercise program on persistent cancer-related fatigue after treatment. Ann Oncol. 2008;19:1495–9.CrossRefPubMedGoogle Scholar
  30. 30.
    Cramp F, Daniel J. Exercise for the management of cancer-related fatigue in adults. Cochrane Database Syst Rev. 2008:CD006145.Google Scholar
  31. 31.
    Dirksen SR, Epstein Dr. Efficacy of an insomnia intervention on fatigue, mood and quality of life in breast cancer survivors. J Adv Nurs. 2008;61:664–75.CrossRefPubMedGoogle Scholar
  32. 32.
    Epstein DR, Dirksen SR. Randomized trial of a cognitive-behavioral intervention for insomnia in breast cancer survivors. Oncol Nurs Forum. 2007;34:E51–9.CrossRefPubMedGoogle Scholar
  33. 33.
    Espie CA, Fleming L, Cassidy J, et al. Randomized controlled clinical effectiveness trial of cognitive behavior therapy compared with treatment as usual for persistent insomnia in patients with cancer. J Clin Oncol. 2008;26:4651–8.CrossRefPubMedGoogle Scholar
  34. 34.
    Cohen L, Warneke C, Fouladi RT, et al. Psychological adjustment and sleep quality in a randomized trial of the effects of a Tibetan yoga intervention in patients with lymphoma. Cancer. 2004;100:2253–60.CrossRefPubMedGoogle Scholar
  35. 35.
    Carlson LE, Garland SN. Impact of mindfulness-based stress reduction (MBSR) on sleep, mood, stress and fatigue symptoms in cancer outpatients. Int J Behav Med. 2005;12:278–85.CrossRefPubMedGoogle Scholar
  36. 36.
    Vickers AJ, Straus DJ, Fearon B, et al. Acupuncture of post chemotherapy fatigue: a phase II study. J Clin Oncol. 2004;22:1731–5.CrossRefPubMedGoogle Scholar
  37. 37.
    Molassiotis A, Sylt P, Diggins H. The management of cancer−related fatigue after chemotherapy with acupuncture and acupressure: a randomized controlled trial. Complement Ther Med. 2007;15:228–37.CrossRefPubMedGoogle Scholar
  38. 38.
    Wargin W, Patrick K, Kilts C, et al. Pharmacokinetics of methylphenidate in man, rat and monkey. J Pharmacol Exp Ther. 1983;226:382–6.PubMedGoogle Scholar
  39. 39.
    Bruera E, Driver L, Barnes EA, et al. Patient-controlled methylphenidate for the management of fatigue in patients with advanced cancer: a preliminary report. J Clin Oncol. 2003;21:4439–43.CrossRefPubMedGoogle Scholar
  40. 40.
    Sarhill N, Walsh D, Nelson KA, et al. Methylphenidate for fatigue in advanced cancer: a prospective open-label pilot study. Am J Hosp Palliat Care. 2001;18:187–92.CrossRefPubMedGoogle Scholar
  41. 41.
    Bruera E, Valero V, Driver L, et al. Patient controlled methylphenidate for cancer fatigue: a double-blind, randomized, placebo-controlled trial. J Clin Oncol. 2006;24:2073–8.CrossRefPubMedGoogle Scholar
  42. 42.
    Kaleita TA, Wellisch DK, Graham CA, et al. Pilot study of modafinil for treatment of neurobehavioral dysfunction and fatigue in adult patients with brain tumors (abstract). J Clin Oncol. 2006;24:58s.Google Scholar
  43. 43.
    Morrow GR, Jean-Pierre P, Roscoe JA, et al. A phase III randomized, placebo-controlled, double-blind trial of a eugeroic agent in 642 cancer patients reporting fatigue during chemotherapy: a URCC CCOP study (abstract). J Clin Oncol. 2008;26:504s.CrossRefGoogle Scholar
  44. 44.
    Morrow GR, Hickok JT, Roscoe JA, et al. Differential effects of paroxetine on fatigue and depression: a randomized, double-blind trial from the University of Rochester Cancer Center Community Clinical Oncology Program. J Clin Oncol. 2003;21:4635–41.CrossRefPubMedGoogle Scholar
  45. 45.
    Stockler MR, O’Connell R, Nowak AK, et al. Effect of sertraline on symptoms and survival in patients with advanced cancer, but without major depression: a placebo-controlled double blind randomized trial. Lancet Oncol. 2007;8:603–12.CrossRefPubMedGoogle Scholar
  46. 46.
    Palesh O, Mustian KM, Roscoe JA, et al. Effect of paroxetine on depression and insomnia in 547 fatigued cancer patients undergoing chemotherapy (abstract). J Clin Oncol. 2008;26:502s.Google Scholar
  47. 47.
    Moss EL, Simpson JS, Pelletier G, et al. An open-label study of the effects of bupropion SR on fatigue, depression and quality of life of mixed-site cancer patients and their partners. Psychooncology. 2006;15:259–67.CrossRefPubMedGoogle Scholar
  48. 48.
    Bruera E, Roca E, Cedaro L, et al. Action of oral methylprednisolone in terminal cancer patients: a prospective randomized double-blind study. Cancer Treat Rep. 1985;69:751–4.PubMedGoogle Scholar
  49. 49.
    Bruera E, El Osta B, Valero V, et al. Donepezil for cancer fatigue: a double-blind, randomized, placebo-controlled trial. J Clin Oncol. 2007;25:3475–81.CrossRefPubMedGoogle Scholar

Copyright information

© Society of General Internal Medicine 2009

Authors and Affiliations

  1. 1.Department of General Internal Medicine, Ambulatory Treatment and Emergency CenterThe University of Texas M.D., Anderson Cancer CenterHoustonUSA

Personalised recommendations